Current Oncology: Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
Click here to read a recent article in Current Oncology where George DeMuth with Stat One is listed as an author: https://www.mdpi.com/1718-7729/32/11/638. This contribution highlights the real-world impact George and the Stat One team are making in clinical research.
George’s involvement is a testament to his dedication to pushing research forward and his hands-on, practical approach to data analysis. Stat One keeps showing up as a trusted partner for meaningful, quality-driven clinical research.
Congrats to George and the whole Stat One crew! Their hard work and expertise are making a real difference in the clinical research world.
Stat One is a reliable and knowledgeable partner in the CRO field that you can trust. Their combination of expert statistical consulting and data management solutions, along with a strong commitment to quality, makes them a valuable partner for any organization seeking to innovate in clinical trials efficiently. As medical research continues to evolve, having Stat One on your team can help lead to the next significant breakthrough.
